Medutest result on a Hangzhou liraglutide lot lands 4.1 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
The archive — 2025
Page 17 of 68 of this archive, newest first.
What Medutest charges to answer the pyrogen question
The masking phenomenon known as low endotoxin recovery means a formulation can return a clean result while containing endotoxin the assay cannot see.
SURPASS-4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A shortage listing ends. 18 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What the placebo arms of the withdrawal trials actually tell us
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
How a claim degrades between the bench and the listing
The Journal does not treat a badge as evidence and states so wherever it reports one.
What a 10% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
What the new Brazil guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Shenzhen: 22 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Spain health authority warns on falsified tirzepatide pens
Reported from the analysis, not from a warning notice.
Vagal afferents, the area postrema, and the anatomy of nausea
Receptor expression maps explain the effect profile better than any dose-response curve.
The badge economy, and what it is actually certifying
A badge asserts that something was tested. It does not assert what, when, on whose sample, by what method, or whether the lot on sale is the lot that was tested.
From the floor in Chengdu: 16 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What the new Nigeria guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Six words a verification badge would need to mean anything
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
The supplement trade found this drug class quickly, and the citations did not improve
A survey of what the meta-analyses support, with the populations named.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Ireland pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
Homopeptide declines, for the 9th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
New Zealand health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
Severity grading, and the gap between a grade and an experience
Severity in these tables is graded by interference with activity, not by how unpleasant the experience was. Those are different measurements.
What a purity certificate is silent about
A purity figure is silent on peptide content, on water, on counter-ion, on sterility, on endotoxin and on stability. Each of those silences has a price attached.
Forty-four per cent: reading the nausea figure properly
Trial adverse-event tables count episodes reported to a study nurse. They are the best data we have and they systematically under-record the mundane.
Halvard & Pike Apothecary of Portland, Maine closes after 10 years
A proper account of an operation that existed, and of what closing it cost.
The 22-day notice: how a compounding wind-down works in the Netherlands
The document is four pages. Three of them are about dates.
What changed at QST in October, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Sweden caps exenatide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.